
|Slideshows|June 21, 2019
FDA approvals you might have missed
Author(s)Miranda Hester
A look at 5 recent approvals from the US Food and Drug Administration (FDA), including treatment for systemic lupus erythematosus, a new gene therapy, and pain relief for patients with irritable bowel syndrome.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
The future of PMOS care: GLP-1 therapy and weight-loss caution
2
AAP expands RSV immunization recommendations for high-risk children
3
AAP recommends 2026-2027 COVID-19 vaccine for all infants 6 to 23 months and at-risk older children
4
Top 5 pediatric health headlines you missed in August 2026
5






